NCT06906341 2025-10-22
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Corcept Therapeutics
Phase 2 Recruiting
Corcept Therapeutics
Massachusetts General Hospital
Fujian Cancer Hospital
Sheba Medical Center